Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial - Martinez, F J; Rabe, K F; Sethi, S (Am J Respir Crit Care Med, 2016)
et al.